FDA’s Sachdev resigns
This article was originally published in The Tan Sheet
Deputy Commissioner for Policy Amit Sachdev formally resigns from the agency, Acting Commissioner Lester Crawford announces in an internal memorandum. Crawford cited Sachdev's work with Congress on FDA oversight, his contributions to expanding the agency's access to more resources for its various centers and leadership in speeding up review of medicines to treat HIV/AIDS under the White House's global AIDS initiative. Sachdev, whose last day was March 25, has not disclosed his future plans...
You may also be interested in...
FDA Commissioner Confirmation Clears The Way For Personnel Changes
The confirmation of FDA Commissioner Lester Crawford will allow for a reorganization of upper level management at the agency
Travere Looks Ahead To Phase III In Homocystinuria
The latest data from a Phase I/II study shows that pegtibatinase can yield a rapid, sustained reduction in homocysteine, the protein behind the underlying cause of the rare disease.
Minute Insight: Inbound Health Now Offers Post-Surgical Hospital Care At Patients’ Homes
The hospital-to-home care movement is rising, and Inbound Health wants to be at the forefront of enabling health systems and health plans nationwide to bring hospital-level care into the home, now adding general surgery to its offerings.